<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0009405" disease_type="Neoplastic Process" abbrv="">Lynch syndrome</z:e> (LS) is characterised by the development of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, <z:e sem="disease" ids="C0476089" disease_type="Neoplastic Process" abbrv="">endometrial cancer</z:e> and various other <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>, and is caused by a mutation in one of the mismatch repair genes: MLH1, MSH2, MSH6 or PMS2 </plain></SENT>
<SENT sid="1" pm="."><plain>In 2007, a group of European experts (the Mallorca group) published guidelines for the clinical management of LS </plain></SENT>
<SENT sid="2" pm="."><plain>Since then substantial new information has become available necessitating an update of the guidelines </plain></SENT>
<SENT sid="3" pm="."><plain>In 2011 and 2012 workshops were organised in Palma de Mallorca </plain></SENT>
<SENT sid="4" pm="."><plain>A total of 35 specialists from 13 countries participated in the meetings </plain></SENT>
<SENT sid="5" pm="."><plain>The first step was to formulate important clinical questions </plain></SENT>
<SENT sid="6" pm="."><plain>Then a systematic literature search was performed using the Pubmed database and manual searches of relevant articles </plain></SENT>
<SENT sid="7" pm="."><plain>During the workshops the outcome of the literature search was discussed in detail </plain></SENT>
<SENT sid="8" pm="."><plain>The guidelines described in this paper may be helpful for the appropriate management of families with LS </plain></SENT>
<SENT sid="9" pm="."><plain>Prospective controlled studies should be undertaken to improve further the care of these families </plain></SENT>
</text></document>